OTCMKTS:SUVPF Sartorius Aktiengesellschaft (SUVPF) Stock Price, News & Analysis $255.60 +16.83 (+7.05%) As of 02:55 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About Sartorius Aktiengesellschaft Stock (OTCMKTS:SUVPF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SUVPF alerts:Sign Up Key Stats Today's Range$255.60▼$255.6050-Day Range$238.78▼$281.3252-Week Range$208.00▼$312.93Volume16 shsAverage Volume155 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sartorius Aktiengesellschaft is a global life science and laboratory equipment supplier headquartered in Göttingen, Germany. The company designs, manufactures and markets instruments and consumables that support research, development and production of biopharmaceuticals, vaccines and other high-value biologics. Its customer base spans academic and governmental research institutions as well as pharmaceutical and biotechnology firms. Operations are structured into two core segments: Bioprocess Solutions and Lab Products & Services. The Bioprocess Solutions division delivers single-use systems and process technologies for upstream and downstream production, including cell culture media, filtration units and chromatography platforms. The Lab Products & Services division offers precision laboratory instruments—such as analytical balances, lab filtration devices and cell analysis tools—alongside associated consumables and calibration services. Founded in 1870 by Florenz Sartorius, the company has expanded from a regional scales manufacturer into a leading supplier of life science tools. Today, it maintains production sites, R&D centers and sales offices across Europe, North America, Asia and other regions, supporting operations in more than 110 countries through a network of subsidiaries and distribution partners. Sartorius Aktiengesellschaft is governed under German corporate law by an executive board and a supervisory board. The company continues to invest in research and development and strategic partnerships to broaden its product portfolio and enhance process efficiency, addressing the growing global demand for scalable, high-quality solutions in both laboratory research and commercial biopharmaceutical manufacturing.AI Generated. May Contain Errors. Read More Receive SUVPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sartorius Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SUVPF Stock News HeadlinesSartorius Aktiengesellschaft Non-GAAP EPS of €4.05, revenue of €3.38B; initiates FY25 soft outlookJanuary 28, 2025 | seekingalpha.comSartorius’s Shares Drop on Outlook Cut, Preliminary 3Q DeclinesOctober 13, 2023 | finance.yahoo.comYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners guide...please take a few seconds and download it right now before your download link expires. That way, no matter what it costs in the future, you'll have a free copy on your computer.May 19 at 1:00 AM | Profits Run (Ad)Sartorius Aktiengesellschaft (OTC: SUVP.F)July 22, 2023 | fool.comSRT3.DE - Sartorius AktiengesellschaftJune 19, 2023 | de.finance.yahoo.comSartorius AG Pfd.March 20, 2023 | barrons.comSartorius Aktiengesellschaft GAAP EPS of Є9.57, revenue of Є4.17BJanuary 26, 2023 | seekingalpha.comSATG.DE - Sartorius AG | Stock Price & Latest News | ReutersOctober 19, 2022 | reuters.comSee More Headlines SUVPF Stock Analysis - Frequently Asked Questions How have SUVPF shares performed this year? Sartorius Aktiengesellschaft's stock was trading at $268.75 at the start of the year. Since then, SUVPF stock has decreased by 4.9% and is now trading at $255.60. How do I buy shares of Sartorius Aktiengesellschaft? Shares of SUVPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/19/2026Next Earnings (Estimated)7/23/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:SUVPF CIKN/A Webwww.sartorius.com Phone495513080FaxN/AEmployees14,614Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:SUVPF) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sartorius Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share Sartorius Aktiengesellschaft With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.